Abstract
Parkinson's disease (PD) is an extra-pyramidal neurodegenerative disorder, in which alterations of the immune system are involved. Interleukin (IL)-15 stimulates cellular immune response and induces growth and differentiation of various immune cells. RANTES, promoting leukocyte infiltration to sites of inflammation, mediates the trafficking and homing of immune cells. To clarify the potential effect of levodopa on the immunological network of PD, we analyzed IL-15 and RANTES serum levels in PD patients, treated or not with levodopa, and in healthy donors. Levodopa-treated patients showed significantly higher IL-15 and RANTES circulating levels with respect to healthy controls and higher, although not significantly, levels with respect to untreated patients. So, we hypothesize that the immunological alterations found in PD may be linked, at least in part, to levodopa therapy.
Full Text
The Full Text of this article is available as a PDF (114.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bessler H., Djaldetti R., Salman H., Bergman M., Djaldetti M. IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson's disease. Biomed Pharmacother. 1999 Apr;53(3):141–145. doi: 10.1016/S0753-3322(99)80079-1. [DOI] [PubMed] [Google Scholar]
- Fehniger T. A., Caligiuri M. A. Interleukin 15: biology and relevance to human disease. Blood. 2001 Jan 1;97(1):14–32. doi: 10.1182/blood.v97.1.14. [DOI] [PubMed] [Google Scholar]
- Perera L. P., Goldman C. K., Waldmann T. A. IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J Immunol. 1999 Mar 1;162(5):2606–2612. [PubMed] [Google Scholar]
- Terreni L., De Simoni M. G. Role of the brain in interleukin-6 modulation. Neuroimmunomodulation. 1998 May-Aug;5(3-4):214–219. doi: 10.1159/000026339. [DOI] [PubMed] [Google Scholar]